• Sourcing Solutions
  • Services & Membership
  • Help & Community
Business Type: Manufacturer, Distributor/Wholesaler
Location: Singapore
Main Products: glucose monitoirng system,glucose test strips,IVDs,rapid test kits,rapid screen tests
Total Employees: 11 - 50 People
Total Annual Revenue: US$10 Million - US$50 Million
Year Established: 2010
Top 3 Markets: Africa 40.00% South Asia 5.00% North America 5.00%
JAL Innovation SINGAPORE's ultimate goal is to serve our global partners with a truly integrated bio...
JAL Innovation SINGAPORE's ultimate goal is to serve our global partners with a truly integrated biomedical manufacturing facility with offering of a wide range of proprietary diabetic monitoring systems and in-vitro diagnostic test kits.

Our vision is to serve our global partners and their valued customers by providing a safe, reliable and cost effective solutions for diabetic monitoring and in-vitro diagnostic testing.

We specialized in manufacturing advanced rapid in-vitro immunodiagnostic test systems and electrical bio sensing systems, particularly blood glucose monitoring system for home and professional uses.

We have been year-marked to be one of the most promising emerging biomedical manufacturing company and a leading exporter of In-Vitro Diagnostic products in Singapore.

Our iCARE Global Brand of Medical products cover Health Screening; Detection of Blood Glucose Levels, Infectious Diseases, Fertility, Chronic & Critical Illnesses Alcohol and Drugs Abuses.

Trade Capacity View More >

Trade & Market
Main Markets Total Revenue(%)
Africa 40.00%
South Asia 5.00%
North America 5.00%
Southern Europe 5.00%
Central America 5.00%
Western Europe 5.00%
Mid East 5.00%
Oceania 5.00%
Southeast Asia 5.00%
South America 5.00%
Export Percentage: 91% - 100%
No. of Employees in Trade Department: 6-10 People
Email to this supplier